Aprea Therapeutics Inc (APRE:NASDAQ)

$0.8439 -0.04 (-4.10%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 78

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly

Analysed Aprea Therapeutics Inc (APRE:NASDAQ) News Sources

Aprea reports second partial response in phase 1 APR-1051 trial

MyChesCo on MSN

external link

Aprea to present at Oppenheimer Healthcare Conference

MyChesCo on MSN

external link

MAIA Pharmaceuticals Selected by Asahi Kasei Pharma to Advance Teribone™ for US Osteoporosis Patients

Medindia

external link
APRE stock
APRE stock price
APRE stock price today
APRE stock prediction
APRE earnings date
APRE news
APRE price
APRE share
APRE share price
APRE shares
APRE ceo
APRE premarket
$APRE
APRE ticker
APRE after hours
APRE stock
APRE stock price
APRE stock price today
APRE stock prediction
APRE earnings date
APRE news
APRE price
APRE share
APRE share price
APRE shares
APRE ceo
APRE premarket
$APRE
APRE ticker
APRE after hours

Aprea Therapeutics Inc (APRE:NASDAQ) FAQs

toggle

What is the current price of Aprea Therapeutics Inc (APRE:NASDAQ)?

The current price of Aprea Therapeutics Inc (APRE:NASDAQ) is $0.8439.


toggle

Aprea Therapeutics Inc (APRE:NASDAQ) absolute price change since previous trading day?

The absolute price change of Aprea Therapeutics Inc (APRE:NASDAQ) since the previous trading day is $-0.04.


toggle

Aprea Therapeutics Inc (APRE:NASDAQ) percentage price change since previous trading day?

The percentage price change of Aprea Therapeutics Inc (APRE:NASDAQ) since the previous trading day is -4.10%.


toggle

What is This Week's average sentiment score for Aprea Therapeutics Inc (APRE:NASDAQ)?

This Week's average sentiment score for Aprea Therapeutics Inc (APRE:NASDAQ) is 78 out of 100.


toggle

What is This Week's average sentiment for Aprea Therapeutics Inc (APRE:NASDAQ)?

This Week's sentiment for Aprea Therapeutics Inc (APRE:NASDAQ) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.